164 related articles for article (PubMed ID: 38294264)
1. [Diagnosis and management of pruritus associated with chronic kidney disease in hemodialyzed patients].
Lanot A; Misery L; Rostoker G; Testa A; Chauveau P; Touzot M; Florens N; Bataille P
Nephrol Ther; 2024 Feb; 20(1):50-60. PubMed ID: 38294264
[TBL] [Abstract][Full Text] [Related]
2. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
Yosipovitch G; Awad A; Spencer RH; Munera C; Menzaghi F
J Am Acad Dermatol; 2023 Aug; 89(2):261-268. PubMed ID: 37059302
[TBL] [Abstract][Full Text] [Related]
3. Impact of Difelikefalin on the Health-Related Quality of Life of Haemodialysis Patients with Moderate-To-Severe Chronic Kidney Disease-Associated Pruritus: A Single-Arm Intervention Trial.
Fotheringham J; Guest J; Latus J; Lerma E; Morin I; Schaufler T; Soro M; Ständer S; Zeig S
Patient; 2024 Mar; 17(2):203-213. PubMed ID: 38196014
[TBL] [Abstract][Full Text] [Related]
4. Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis.
Weiner DE; Schaufler T; McCafferty K; Kalantar-Zadeh K; Germain M; Ruessmann D; Morin I; Menzaghi F; Wen W; Ständer S
Nephrol Dial Transplant; 2024 Jun; 39(7):1125-1137. PubMed ID: 37968132
[TBL] [Abstract][Full Text] [Related]
5. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
Fishbane S; Jamal A; Munera C; Wen W; Menzaghi F;
N Engl J Med; 2020 Jan; 382(3):222-232. PubMed ID: 31702883
[TBL] [Abstract][Full Text] [Related]
6. Difelikefalin for pruritus associated with renal disease.
Manenti L; Fenaroli P
Drugs Today (Barc); 2022 Sep; 58(9):427-435. PubMed ID: 36102903
[TBL] [Abstract][Full Text] [Related]
7. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis.
Rastogi A; Fishbane S; Lerma E
Expert Rev Clin Pharmacol; 2023 May; 16(5):387-400. PubMed ID: 37010031
[TBL] [Abstract][Full Text] [Related]
8. [Difelikefalin and treatment of severe pruritus associated with chronic kidney disease - Real-life retrospective study in a dialysis center].
Brasme R; Cartery C; Goubet M; Hennino MF; Maisonneuve N
Nephrol Ther; 2024 Jun; 20(3):1-9. PubMed ID: 38874419
[TBL] [Abstract][Full Text] [Related]
9. Difelikefalin: A New κ-Opioid Receptor Agonist for the Treatment of Hemodialysis-Dependent Chronic Kidney Disease-Associated Pruritus.
Fugal J; Serpa SM
Ann Pharmacother; 2023 Apr; 57(4):480-488. PubMed ID: 35942600
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease-associated pruritus in patients undergoing hemodialysis: Xerosis and topical therapy.
Krismi A; Danarti R; Setiabudi IIDPP; Wirohadidjojo YW
Hemodial Int; 2023 Apr; 27(2):91-104. PubMed ID: 36811513
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease-associated pruritus: what is known and its application in children.
Shah S; Onugha E; Swartz SJ
Pediatr Nephrol; 2024 Jan; 39(1):25-35. PubMed ID: 37171581
[TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis.
Thokala P; Hnynn Si PE; Hernandez Alava M; Sasso A; Schaufler T; Soro M; Fotheringham J
Pharmacoeconomics; 2023 Apr; 41(4):457-466. PubMed ID: 36735201
[TBL] [Abstract][Full Text] [Related]
13. Difelikefalin: First Approval.
Deeks ED
Drugs; 2021 Nov; 81(16):1937-1944. PubMed ID: 34674115
[TBL] [Abstract][Full Text] [Related]
14. [Pruritus associated chronic kidney disease].
Lanot A; Kottler D; Béchade C
Nephrol Ther; 2021 Dec; 17(7):488-495. PubMed ID: 34654672
[TBL] [Abstract][Full Text] [Related]
15. Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study.
Weiner DE; Vervloet MG; Walpen S; Schaufler T; Munera C; Menzaghi F; Wen W; Bhaduri S; Germain MJ;
Kidney Med; 2022 Oct; 4(10):100542. PubMed ID: 36185706
[TBL] [Abstract][Full Text] [Related]
16. Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2.
Fishbane S; Clegg DJ; Lerma EV; Rastogi A; Budden J; Morin I; Wen W; Menzaghi F; Topf J
Am J Nephrol; 2024; 55(3):329-333. PubMed ID: 38253036
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, patient burden and physicians' perception of pruritus in haemodialysis patients.
Engler F; Kerschbaum J; Keller F; Mayer G;
Nephrol Dial Transplant; 2024 Jan; 39(2):277-285. PubMed ID: 37429597
[TBL] [Abstract][Full Text] [Related]
18. Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy.
Ahdoot RS; Kalantar-Zadeh K; Burton JO; Lockwood MB
Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):63-71. PubMed ID: 34750335
[TBL] [Abstract][Full Text] [Related]
19. Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus.
Vernon MK; Swett LL; Speck RM; Munera C; Spencer RH; Wen W; Menzaghi F
J Patient Rep Outcomes; 2021 Dec; 5(1):134. PubMed ID: 34952964
[TBL] [Abstract][Full Text] [Related]
20. Intravenous difelikefalin for the treatment of hemodialysis pruritus.
Mahmoud RH; Mahmoud O; Yosipovitch G
Expert Rev Clin Immunol; 2024; 20(1):31-37. PubMed ID: 37847514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
